Presented for research literature review only Szilgyi M (1998)
Although these two drugs were originally developed to improve glycemic control in people with type 2 diabetes, they simultaneously cause significant weight loss in these patients, without too many major side effects, and could therefore represent a new therapeutic strategy for the normalization of body weight
A real pharma trial for gut disease ran in the early 2000s, then the results quietly vanished
y l nhm i tng c th cn nhc b sung h tr t bn trong: Ngi c ln da xn mu, thm sm : Nhng ngi gp vn v sc t nh nm, tn nhang, m nu do nh nng mt tri hoc thm sau mn
Mbuntum, GLP-1s have been shown to improve cardiovascular health because obesity is closely linked to heart disease
Interestingly, these findings can be generalized to the pentose phosphate pathway, which is another major source of reducing power and nucleotides